Abstract
Antimicrobial resistance among pathogenic organisms is now a persistent problem and of tremendous public health care concern around the globe. These pathogens are able to develop mechanisms of resistance, the antimicrobial agents that were at one time the drug of choice. They continue to develop various mechanisms of resistance either by intrinsic or acquired, and have been able to transfer and accept different resistance genes, given rise to multi-drugs resistance bacteria called superbugs. This new phenomenon has caused an increase in the incidence of nosocomial infections making the treatment problematic for the health care providers. Resistance to antimicrobial agents is fast becoming a norm and is an enormous challenge worldwide. Key words: Antimicrobial resistance, antimicrobial agent, pathogen, mechanism, superbug.
Highlights
Issues of resistance of pathogens to antimicrobial agentsAntimicrobial resistance among pathogenic organisms is a persistent problem and of tremendous public health care concern around the globe
Antimicrobial resistance developed by pathogenic organisms is a global menace and has escalated over the years by the emergence of multi-drug resistant strains among these pathogens (Gould et al, 2010; Lister et al, 2009)
Examples of clinically important pathogens that are increasingly becoming multi-drug resistance to antibiotics in use are Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterococcus faecalis
Summary
Antimicrobial resistance among pathogenic organisms is a persistent problem and of tremendous public health care concern around the globe These pathogens are able to develop mechanisms of resistance, the antimicrobial agents that were at one time the drug of choice. They continue to develop various mechanisms of resistance either by intrinsic or acquired, and have been able to transfer and accept different resistance genes, given rise to multi-drugs resistance bacteria called superbugs. This new phenomenon has caused an increase in the incidence of nosocomial infections making the treatment problematic for the health care providers.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
